- 2025 - 2030 能登半島地震後の粉塵曝露による自己免疫性肺胞蛋白症発症に関する前方視的研究
- 2025 - 2028 Molecular basis of antibiotic-induced resistance mechanisms on the ribosomes of pathogenic bacteria
- 2024 - 2028 Unveiling fate of non-tuberculous mycobacteria and control of their infection risk in hospital water supply system
- 2024 - 2027 The research and development of novel treatment options to mycobacteriosis focusing on the onset or aggravating factors and considering the drug kinetics and its safety
- 2023 - 2026 Isolation and analysis of Mycobacterium ulcerans associating with environment-human transmission using single-cell technology
- 2023 - 2026 環境/臨床分離株のpathogenomics解析による肺MABC症成立と進行に関わる菌側因子の解明
- 2023 - 2026 Machine Learningを援用した非結核性抗酸菌の鑑別
- 2020 - 2023 Establishment of next-generation water supply system to control risk of non-tuberculous Mycobacterium
- 2019 - 2022 Identification of virulence factors of Mycobacterium ulcerans for the transmission from natural environments to humans
- 2018 - 2022 Integrated research to fight against Buruli ulcer and other skin NTDs in West Africa
- 2018 - 2021 皮膚ブルーリ潰瘍原因菌のゲノム・エピゲノム比較解析、感染源捜索と新規治療薬開発
- 2018 - 2021 活性型・抑制型自然免疫受容体解析による抗酸菌潜伏および持続感染の成立、維持と再活性化機序解明に基づく新規治療法開発
- 2018 - 2021 ハンセン病等の予防・診断・治療の開発に向けた研究
- 2017 - 2020 クラリスロマイシン耐性肺MAC症に対する新たな治療薬の開発
- 2017 - 2020 非結核性抗酸菌症の発生動向把握及び診断・治療法の開発に向けた研究
- 2016 - 2019 Elucidation of miRNA-mediated pathophysiology of MAC pulmonary disease
- 2016 - 2019 Development of novel tuberculosis vaccine mainly targeting to humoral immunity
- 2013 - 2017 Analysis of molecular mechanisms of anti-microbial activity of the host in mycobacterial infection
- 2013 - 2016 An analysis of miRNA related host-microbial crosstalk
- 2013 - 2016 Study for pathological Analysis and clinical intervention of pulmonary MAC disease
- 2011 - 2013 Development of early diagnostic and therapeutic methods useful for buruli ulcer control
- 2010 - 2012 Development of early diagnosis and disease stage evaluation method using ribosomal RNA gene in respiratory bacterial infectious diseases
Show all
